89Zr-NY005

N/A

Report date: 2025/10/20 14:27:31

Base Information

Drug Name89Zr-NY005
Drug Alias NameZirconium-89-NY00589Zr-NY005
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugateRadiation-emitting products > Radioactive diagnostic agent +[6] 
Mechanisms of ActionAnti-CLDN18Positron-emission tomography enhancers
TargetsClaudin-18 splice variant 2
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsStomach Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesWuxi Nuoyu Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWuxi Nuoyu Pharmaceutical Technology Co LtdWuxi No 4 People'S Hospital
Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic NeoplasmsStomach Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A